RB1 c.2086A>T ;(p.R696*)

Variant ID: 13-49033949-A-T

NM_000321.2(RB1):c.2086A>T;(p.R696*)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti-angiogenic agent apatinib combination therapy.

Clinical And Translational Medicine
Xu, Gehan G; Cui, Liang L; Li, Jin J; Wang, Quanren Q; Li, Pansong P; Xia, Xuefeng X; Yi, Xin X; Guan, Quanlin Q; Xu, Jianming J
Publication Date: 2022-10

Variant appearance in text: RB1: 2086A>T; R696*
PubMed Link: 36245284
Variant Present in the following documents:
  • CTM2-12-e1086-s010.xlsx, sheet 7
View BVdb publication page



Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series.

International Journal Of Molecular Sciences
Niogret, Julie J; Derangère, Valentin V; Richard, Corentin C; Nuttin, Lisa L; Ghiringhelli, François F; Favier, Laure L; Lefevre, Leila Bengrine LB; Bergeron, Anthony A; Arnould, Laurent L; Boidot, Romain R
Publication Date: 2022-03-19

Variant appearance in text: RB1: Arg696*
PubMed Link: 35328764
Variant Present in the following documents:
  • Main text
  • ijms-23-03343.pdf
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: RB1: 2086A>T; R696*
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page